Keefe, Bruyette & Woods Sees Decision To Retrocede As Good For Reinsurance Group Of America
In a report published Wednesday, Keefe, Bruyette & Woods analyst Ryan Krueger reiterated a Market Perform rating and $95.00 price target on Reinsurance Group of America (NYSE: RGA).
In the report, Keefe, Bruyette & Woods noted, “RGA is retroceding 14% of its U.S. mortality block to Pacific Life, reducing premiums by $450m (5% of consolidated) and freeing up $200m of capital. We view the transaction favorably, as the retroceded business comes from RGA's underperforming 1999-2004 U.S. mortality block that was earning low-single-digit returns. This deal follows a recent embedded value securitization that freed up ~$250m of intermediate-term capital/liquidity. We expect a portion of the capital freed up from these transactions to be redeployed into additional block opportunities and/or share repurchase over time. Assuming $200m of incremental share repurchase and estimated deal costs, we raise 2016E EPS to $9.75 from $9.60, and increase price target to $95.”
Reinsurance Group of America closed on Tuesday at $88.21.
Latest Ratings for RGA
Date | Firm | Action | From | To |
---|---|---|---|---|
Mar 2022 | Credit Suisse | Maintains | Underperform | |
Feb 2022 | Morgan Stanley | Maintains | Underweight | |
Jan 2022 | Jefferies | Initiates Coverage On | Buy |
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted-In: Bruyette & Woods Keefe Ryan KruegerAnalyst Color Reiteration Analyst Ratings